These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12894463

  • 21. Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease.
    Donohue JF, Ohar JA.
    Proc Am Thorac Soc; 2004; 1(3):152-60. PubMed ID: 16113428
    [Abstract] [Full Text] [Related]

  • 22. Inhaled corticosteroids in obstructive airway disease.
    Phua GC, Macintyre NR.
    Respir Care; 2007 Jul; 52(7):852-8. PubMed ID: 17594729
    [Abstract] [Full Text] [Related]

  • 23. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!].
    Rochat T.
    Rev Med Suisse; 2008 Jan 16; 4(140):155-7. PubMed ID: 18309880
    [Abstract] [Full Text] [Related]

  • 24. [Clinical efficacy of inhaled corticosteroids in COPD].
    Kamoi H, Yoshikawa T, Hirata K.
    Nihon Rinsho; 2007 Apr 16; 65(4):696-701. PubMed ID: 17419390
    [Abstract] [Full Text] [Related]

  • 25. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA, Tashkin DP.
    Am J Med; 2007 Aug 16; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [Abstract] [Full Text] [Related]

  • 26. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
    Kiri VA, Bettoncelli G, Testi R, Viegi G.
    Respir Med; 2005 Sep 16; 99(9):1115-24. PubMed ID: 15921904
    [Abstract] [Full Text] [Related]

  • 27. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
    Zietkowski Z, Kucharewicz I, Bodzenta-Lukaszyk A.
    Respir Med; 2005 Jul 16; 99(7):816-24. PubMed ID: 15939243
    [Abstract] [Full Text] [Related]

  • 28. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
    John M, Bosse S, Oltmanns U, Schumacher A, Witt C.
    Respir Med; 2005 Nov 16; 99(11):1418-24. PubMed ID: 15894479
    [Abstract] [Full Text] [Related]

  • 29. [Treatment with inhalation corticosteroids: useful or useless in chronic obstructive pulmonary disease (COPD)?].
    van Schayck CP.
    Ned Tijdschr Geneeskd; 1999 Apr 10; 143(15):778-80. PubMed ID: 10347639
    [Abstract] [Full Text] [Related]

  • 30. Medications for COPD: a review of effectiveness.
    Grimes GC, Manning JL, Patel P, Via RM.
    Am Fam Physician; 2007 Oct 15; 76(8):1141-8. PubMed ID: 17990836
    [Abstract] [Full Text] [Related]

  • 31. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K.
    Allergy; 2005 Mar 15; 60(3):309-16. PubMed ID: 15679715
    [Abstract] [Full Text] [Related]

  • 32. Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease.
    Calverley PM.
    Proc Am Thorac Soc; 2004 Mar 15; 1(3):161-6. PubMed ID: 16113429
    [Abstract] [Full Text] [Related]

  • 33. How and when to use inhaled corticosteroids in chronic obstructive pulmonary disease?
    Antón E.
    Expert Rev Respir Med; 2013 Apr 15; 7(2 Suppl):25-32. PubMed ID: 23551021
    [Abstract] [Full Text] [Related]

  • 34. Inhaled corticosteroids in chronic obstructive pulmonary disease.
    Suissa S, McGhan R, Niewoehner D, Make B.
    Proc Am Thorac Soc; 2007 Oct 01; 4(7):535-42. PubMed ID: 17878466
    [Abstract] [Full Text] [Related]

  • 35. Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder.
    Chen S, Plauschinat CA, Wu N, Fraser K, Boulanger L.
    J Med Econ; 2011 Oct 01; 14(4):458-62. PubMed ID: 21651427
    [Abstract] [Full Text] [Related]

  • 36. Regulation of inflammatory cell function by corticosteroids.
    Belvisi MG.
    Proc Am Thorac Soc; 2004 Oct 01; 1(3):207-14. PubMed ID: 16113436
    [Abstract] [Full Text] [Related]

  • 37. Clinical effects of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Jones PW.
    Proc Am Thorac Soc; 2004 Oct 01; 1(3):167-70. PubMed ID: 16113430
    [Abstract] [Full Text] [Related]

  • 38. Introduction to the Canadian Scientific Advisory Committee on Respiratory and Allergy Therapies: in vivo evaluation for clinical testing in COPD and asthma therapy using generics.
    Mayers I.
    J Aerosol Med Pulm Drug Deliv; 2012 Aug 01; 25(4):204-8. PubMed ID: 22007673
    [Abstract] [Full Text] [Related]

  • 39. Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD.
    Cazzola M, Dahl R.
    Chest; 2004 Jul 01; 126(1):220-37. PubMed ID: 15249466
    [Abstract] [Full Text] [Related]

  • 40. [The choice and administration of corticoids in COPD].
    Yernault JC, Sternon J.
    Rev Med Brux; 2002 Apr 01; 23(2):96-101. PubMed ID: 12056065
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.